Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 190318011000036110 | Tazocin 4 g/500 mg (piperacillin 4 g + tazobactam 500 mg) powder for injection, 4.5 g vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 190320011000036118 | Tazocin 4 g/500 mg powder for injection, 4.5 g vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | has intended active ingredient | tazobactam | true | Inferred relationship | Some | 1398236866 | |
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | Is a | Tazocin 4 g/500 mg | true | Inferred relationship | Some | ||
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | Is a | piperacillin 4 g + tazobactam 500 mg injection, 4.5 g vial | true | Inferred relationship | Some | ||
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | has intended active ingredient | piperacillin | true | Inferred relationship | Some | 477492030 | |
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | has Australian BoSS | piperacillin | true | Inferred relationship | Some | 477492030 | |
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | has Australian BoSS | tazobactam | true | Inferred relationship | Some | 1398236866 | |
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | has unit of use | vial | true | Inferred relationship | Some | 1398236867 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | has TPUU | True | Tazocin 4 g/500 mg powder for injection, 4.5 g vial | Inferred relationship | Some | 1 |
| Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | has TPUU | True | Tazocin 4 g/500 mg powder for injection, 4.5 g vial | Inferred relationship | Some | 1 |
| Tazocin 4 g/500 mg powder for injection, 4.5 g vial | has TPUU | True | Tazocin 4 g/500 mg powder for injection, 4.5 g vial | Inferred relationship | Some | 1 |
| Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | has TPUU | True | Tazocin 4 g/500 mg powder for injection, 4.5 g vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR